Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2 trial update reporting the determination of a safe dose of romiplostim (AMG 531) in patients with myelodysplastic syndromes, with re…
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil [NA]
This clinical trial update reports termination of a study evaluating tacrolimus with mycophenolate mofetil for graft-versus-host disease pro…
-
CLINICAL_TRIALS trial_result · 2010-10-14Clinical Trial Update: Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders [NA]
This clinical trial update documents the status of a non-myeloablative allogeneic transplant trial for myelodysplastic syndromes and myelopr…
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating bone marrow transplantation with cyclophosphamide and total-body irradiation in patients with hematologic …
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: An Extension to Study AZA PH GL 2003 CL 001 Allowing for Continuation of Azacitidine Treatment in Patients With Myelodysplastic Syndromes (MDS) [Phase 3]
Extension study to continue azacitidine in patients with myelodysplastic syndromes after completion of the main AZA PH GL 2003 CL 001 trial.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
A Phase 1 clinical trial evaluates total-body irradiation with cyclophosphamide and stem cell transplantation in patients with hematologic c…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial tested total-body irradiation with thiotepa and fludarabine as conditioning before donor stem cell transplant in …
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients [NA]
A completed clinical trial update examining the emotional needs of caregivers of stem cell transplantation patients is reported.
-
CLINICAL_TRIALS trial_result · 2010-09-20Clinical Trial Update: Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant [Phase 1]
Phase 1 clinical trial update on cellular adoptive immunotherapy for patients with acute myeloid leukemia, acute lymphoblastic leukemia, or …
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder [Phase 1, Phase 2]
Phase 1/2 clinical trial update on donor peripheral stem cell transplantation for patients with acute myeloid leukemia, myelodysplastic synd…
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes [Phase 2]
A Phase 2 clinical trial evaluating anti-thymocyte globulin and etanercept for myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2010-09-06Clinical Trial Update: Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia [Phase 3]
A Phase 3 trial evaluating daunorubicin and cytarabine with or without zosuquidar in older patients with newly diagnosed acute myeloid leuke…
-
CLINICAL_TRIALS research · 2010-09-03Clinical Trial Update: Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure [Phase 2]
Phase 2 clinical trial exploring decitabine for myelodysplastic syndrome after azacitidine failure.
-
CLINICAL_TRIALS trial_result · 2010-08-09Clinical Trial Update: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluating high-dose busulfan and high-dose cyclophosphamide conditioning followed by donor bone marrow transplantation in p…
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care [Phase 3]
A phase 3 trial comparing azacitidine to conventional care in high-risk myelodysplastic syndromes has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 3]
Phase 3 clinical trial evaluating combination chemotherapy in children with newly diagnosed acute myeloid leukemia or myelodysplastic syndro…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Phase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Syndromes (0683-064) [Phase 2]
Phase IIa study of vorinostat (SAHA) in lower-risk myelodysplastic syndromes was terminated; results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
A Phase 2 trial evaluating high-dose chemotherapy followed by peripheral stem cell transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial evaluating the combination of fludarabine, carboplatin, and topotecan in relapsed/refractory acute leukemia or advanc…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions [Phase 2]
Phase 2 pilot trial evaluating unrelated umbilical cord blood transplantation for leukemia and myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS [Phase 2]
A Phase 2 clinical trial evaluating the combination of fludarabine, carboplatin, topotecan, and thalidomide in relapsed/refractory acute mye…
-
CLINICAL_TRIALS trial_result · 2010-06-09Clinical Trial Update: Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality [Phase 2]
Phase 2 trial assessing lenalidomide safety and efficacy in myelodysplastic syndromes with deletion 5q cytogenetic abnormality has completed…
-
CLINICAL_TRIALS trial_result · 2010-05-28Clinical Trial Update: Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes [Phase 2]
Phase 2 trial updates alternative dosing regimens of subcutaneous azacitidine in myelodysplastic syndromes with completed results posted in …
-
CLINICAL_TRIALS trial_result · 2010-05-25Clinical Trial Update: Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Myelodysplastic Syndromes [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of umbilical cord/placenta-derived mesenchymal stem cells for treating myelodyspla…
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer [Phase 2]
This Phase 2 trial evaluates a conditioning regimen with fludarabine and busulfan followed by donor peripheral stem cell transplantation wit…